Ehsan Moradi-Joo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Ehsan Moradi-Joo has a total of 58 co-authors. Here are the top co-authors by number of shared publications:
- Ahmad Fakhri
Department of Psychiatry, Golestan Hospital, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
4 shared publications - Maryam Ebrahimi Lagha
Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
3 shared publications Mohsen Davarpanah
Instructor of Nursing, Bostan School of Nursing, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
2 shared publications- Samaneh Hashemi
Abadan University of medical Sciences, Abadan, Iran
2 shared publications - Seyede Sareh Kalantarian
Qazvin University of Medical Sciences, Qazvin, Iran
2 shared publications - Siamak Baghaei
Department of Internal Medicine, Ahvaz Branch, Islamic Azad University, Ahvaz, Iran
2 shared publications
Latest Publications
- Open Access
- 26 October 2026
- Published by Brieflands in Jundishapur Journal of Chronic Disease Care
- Vol. 15 (4) , e170932
Association of Empagliflozin Therapy with the Development of Erythrocytosis in Individuals with Type 2 Diabetes and Chronic Kidney Disease
Background: Empagliflozin, a sodium-glucose cotransporter 2 (SGLT2) inhibitor, is widely used in patients with type 2 diabetes mellitus (T2DM) and chronic kidney disease (CKD). In addition to its established cardiorenal benefits, emerging evidence suggests potential effects on hemoglobin levels and erythrocytosis. Objectives: This study aimed to evaluate the association between empagliflozin therapy and erythrocytosis in patients with T2DM and CKD. Methods: This retrospective cohort study included 300 patients with T2DM and CKD treated at two teaching hospitals between 2023 and 2024. Patients were categorized as empagliflozin users (n = 100) or nonusers (n = 200). Erythrocytosis was assessed after ≥ 6 months of continuous therapy. Unadjusted, age- and sex-adjusted, and fully adjusted logistic regression analyses were performed. Results: Erythrocytosis occurred in 8 of 100 users (8%) and 5 of 200 nonusers (2.5%). Empagliflozin use was associated with higher odds of erythrocytosis in the unadjusted model (odds ratio [OR] = 3.64; 95% confidence interval [CI], 0.59 - 22.20; P = 0.161) and the age- and sex-adjusted model (OR = 4.38; 95% CI, 0.66 - 28.90; P = 0.125). In the fully adjusted model, the association remained directionally positive but imprecise (OR = 41.73; 95% CI, 0.11 - 15061.54; P = 0.214). Increasing age was inversely associated with erythrocytosis in the age- and sex-adjusted model (OR = 0.91; 95% CI, 0.84 - 0.97; P = 0.012). Conclusions: Empagliflozin therapy was associated with higher point estimates of the odds of erythrocytosis; however, the lack of statistical significance and wide confidence intervals indicate substantial uncertainty. These findings are exploratory and should be interpreted cautiously. Larger prospective studies are needed to clarify this potential association.
- 26 October 2026
- Published by Brieflands in Jundishapur Journal of Chronic Disease Care
- Vol. 15 (4) , e170932
Open AccessAssociation of Empagliflozin Therapy with the Development of Erythrocytosis in Individuals with Type 2 Diabetes and Chronic Kidney Disease
Background: Empagliflozin, a sodium-glucose cotransporter 2 (SGLT2) inhibitor, is widely used in patients with type 2 diabetes mellitus (T2DM) and chronic kidney disease (CKD). In addition to its established cardiorenal benefits, emerging evidence suggests potential effects on hemoglobin levels and erythrocytosis. Objectives: This study aimed to evaluate the association between empagliflozin therapy and erythrocytosis in patients with T2DM and CKD. Methods: This retrospective cohort study included 300 patients with T2DM and CKD treated at two teaching hospitals between 2023 and 2024. Patients were categorized as empagliflozin users (n = 100) or nonusers (n = 200). Erythrocytosis was assessed after ≥ 6 months of continuous therapy. Unadjusted, age- and sex-adjusted, and fully adjusted logistic regression analyses were performed. Results: Erythrocytosis occurred in 8 of 100 users (8%) and 5 of 200 nonusers (2.5%). Empagliflozin use was associated with higher odds of erythrocytosis in the unadjusted model (odds ratio [OR] = 3.64; 95% confidence interval [CI], 0.59 - 22.20; P = 0.161) and the age- and sex-adjusted model (OR = 4.38; 95% CI, 0.66 - 28.90; P = 0.125). In the fully adjusted model, the association remained directionally positive but imprecise (OR = 41.73; 95% CI, 0.11 - 15061.54; P = 0.214). Increasing age was inversely associated with erythrocytosis in the age- and sex-adjusted model (OR = 0.91; 95% CI, 0.84 - 0.97; P = 0.012). Conclusions: Empagliflozin therapy was associated with higher point estimates of the odds of erythrocytosis; however, the lack of statistical significance and wide confidence intervals indicate substantial uncertainty. These findings are exploratory and should be interpreted cautiously. Larger prospective studies are needed to clarify this potential association.
- Open Access
- 31 August 2026
- Published by Brieflands in Jundishapur Journal of Microbiology
- Vol. 19 (8) , e172198
Prevalence of the luxS Gene and Biofilm Formation in Urinary Tract Klebsiella pneumoniae Isolates
Background: Klebsiella pneumoniae is an important opportunistic pathogen associated with urinary tract infections (UTIs), and its ability to form biofilms contributes to persistence and antimicrobial resistance. Objectives: This study aimed to evaluate the prevalence of Klebsiella isolates from urinary tract infections, their biofilm-forming ability, and the presence of the luxS gene, using molecular methods. Methods: In this cross-sectional study, 51 Klebsiella isolates obtained from urine samples were examined. Species identification was performed using standard microbiological methods, including culture on MacConkey and blood agar, followed by biochemical identification using the IMViC tests. Antimicrobial susceptibility was assessed using the disk diffusion method, biofilm formation was evaluated using the microtiter plate assay, and molecular analysis was performed using polymerase chain reaction (PCR) with specific primers targeting the luxS gene. Data were analyzed using SPSS. Results: Among the 51 samples, 32 isolates were identified as K. pneumoniae and 19 as K. oxytoca. Ampicillin exhibited the highest resistance rate among the Klebsiella isolates. All isolates were susceptible to gentamicin, and 74.5% were susceptible to amikacin. In addition, the luxS gene was detected in 32 of the 51 isolates. Conclusions: The isolates showed high levels of antimicrobial resistance. Biofilm formation may contribute to the persistence of these bacteria and their reduced susceptibility to antimicrobial agents.
- 31 August 2026
- Published by Brieflands in Jundishapur Journal of Microbiology
- Vol. 19 (8) , e172198
Open AccessPrevalence of the luxS Gene and Biofilm Formation in Urinary Tract Klebsiella pneumoniae Isolates
Background: Klebsiella pneumoniae is an important opportunistic pathogen associated with urinary tract infections (UTIs), and its ability to form biofilms contributes to persistence and antimicrobial resistance. Objectives: This study aimed to evaluate the prevalence of Klebsiella isolates from urinary tract infections, their biofilm-forming ability, and the presence of the luxS gene, using molecular methods. Methods: In this cross-sectional study, 51 Klebsiella isolates obtained from urine samples were examined. Species identification was performed using standard microbiological methods, including culture on MacConkey and blood agar, followed by biochemical identification using the IMViC tests. Antimicrobial susceptibility was assessed using the disk diffusion method, biofilm formation was evaluated using the microtiter plate assay, and molecular analysis was performed using polymerase chain reaction (PCR) with specific primers targeting the luxS gene. Data were analyzed using SPSS. Results: Among the 51 samples, 32 isolates were identified as K. pneumoniae and 19 as K. oxytoca. Ampicillin exhibited the highest resistance rate among the Klebsiella isolates. All isolates were susceptible to gentamicin, and 74.5% were susceptible to amikacin. In addition, the luxS gene was detected in 32 of the 51 isolates. Conclusions: The isolates showed high levels of antimicrobial resistance. Biofilm formation may contribute to the persistence of these bacteria and their reduced susceptibility to antimicrobial agents.
- Open Access
- 31 May 2026
- Published by Brieflands in Shiraz E-Medical Journal
- Vol. 27 (5) , e168514
Child Abuse in Health Centers Affiliated with Jundishapur University of Medical Sciences: Prevalence and Associated Factors
Background: Child abuse is a major public health and social concern with potentially long-lasting effects on children’s physical, psychological, and social development. It encompasses physical and emotional abuse, sexual abuse, neglect, and exploitation, and its occurrence is influenced by familial, socioeconomic, and caregiver-related factors. Despite growing evidence on child maltreatment, comprehensive data on its prevalence and associated factors in Iran remain limited, particularly in primary healthcare settings. Health centers offer an important opportunity for the early identification of at-risk children and families. Objectives: This study aimed to determine the prevalence of child abuse and identify its key contributing factors among children attending health service centers affiliated with Jundishapur University of Medical Sciences in Ahvaz, using validated psychometric instruments. Methods: This cross-sectional analytical study included 782 children and their guardians. Indicators of child abuse were assessed using the Dundee Abuse and Care Scale (DACAS) and the Social Health Questionnaire (SHQ). The internal consistency of the DACAS was acceptable (Cronbach's alpha = 0.82). Data were analyzed using SPSS version 26.0. Chi-square tests were used to examine bivariate associations, and multivariable logistic regression was conducted to estimate adjusted odds ratios (aORs) with 95% confidence intervals (CIs). Results: The overall prevalence of identified child abuse was 18.5% (n = 145/782). Emotional neglect (44.8%) and emotional abuse (38.6%) were the most commonly reported forms. The prevalence of abuse was 41.2% in the 5 - 10-year age group, consistent with bivariate analysis (χ2 = 15.98, P = 0.003). Multivariable analysis identified low maternal education (aOR = 3.85, P = 0.001), single-parent family structure (aOR = 2.15, P = 0.003), and emotional neglect (aOR = 15.20, P < 0.001) as significant independent predictors. No statistically significant association was found with parental substance use (P = 0.217) or psychological distress (P = 0.184). Conclusions: Child abuse remains a substantial public health concern in Ahvaz and is strongly associated with low maternal education, unstable family structure, and emotional neglect. These findings underscore the need for integrated health policies that prioritize parenting education, provide targeted economic support, and implement school-based screening to reduce child maltreatment effectively.
- 31 May 2026
- Published by Brieflands in Shiraz E-Medical Journal
- Vol. 27 (5) , e168514
Open AccessChild Abuse in Health Centers Affiliated with Jundishapur University of Medical Sciences: Prevalence and Associated Factors
Background: Child abuse is a major public health and social concern with potentially long-lasting effects on children’s physical, psychological, and social development. It encompasses physical and emotional abuse, sexual abuse, neglect, and exploitation, and its occurrence is influenced by familial, socioeconomic, and caregiver-related factors. Despite growing evidence on child maltreatment, comprehensive data on its prevalence and associated factors in Iran remain limited, particularly in primary healthcare settings. Health centers offer an important opportunity for the early identification of at-risk children and families. Objectives: This study aimed to determine the prevalence of child abuse and identify its key contributing factors among children attending health service centers affiliated with Jundishapur University of Medical Sciences in Ahvaz, using validated psychometric instruments. Methods: This cross-sectional analytical study included 782 children and their guardians. Indicators of child abuse were assessed using the Dundee Abuse and Care Scale (DACAS) and the Social Health Questionnaire (SHQ). The internal consistency of the DACAS was acceptable (Cronbach's alpha = 0.82). Data were analyzed using SPSS version 26.0. Chi-square tests were used to examine bivariate associations, and multivariable logistic regression was conducted to estimate adjusted odds ratios (aORs) with 95% confidence intervals (CIs). Results: The overall prevalence of identified child abuse was 18.5% (n = 145/782). Emotional neglect (44.8%) and emotional abuse (38.6%) were the most commonly reported forms. The prevalence of abuse was 41.2% in the 5 - 10-year age group, consistent with bivariate analysis (χ2 = 15.98, P = 0.003). Multivariable analysis identified low maternal education (aOR = 3.85, P = 0.001), single-parent family structure (aOR = 2.15, P = 0.003), and emotional neglect (aOR = 15.20, P < 0.001) as significant independent predictors. No statistically significant association was found with parental substance use (P = 0.217) or psychological distress (P = 0.184). Conclusions: Child abuse remains a substantial public health concern in Ahvaz and is strongly associated with low maternal education, unstable family structure, and emotional neglect. These findings underscore the need for integrated health policies that prioritize parenting education, provide targeted economic support, and implement school-based screening to reduce child maltreatment effectively.
- Open Access
- 26 April 2026
- Published by Brieflands in Jundishapur Journal of Chronic Disease Care
- Vol. 15 (2) , e167826
Screening and Management Strategies for Chronic Diseases in High-Risk Populations: A Systematic Review
Context: Chronic diseases such as diabetes, cardiovascular conditions, cancers, and respiratory illnesses remain leading causes of global mortality, especially among high-risk groups including the elderly, patients with underlying conditions, and socially disadvantaged populations. Early screening and tailored management strategies are essential to reduce disease burden and improve outcomes. Methods: This systematic review and meta-analysis was conducted in line with PRISMA 2020 guidelines and registered in PROSPERO (CRD42025234789). Comprehensive searches were performed across seven databases (PubMed, Scopus, Web of Science, Embase, Cochrane Library, Google Scholar, and medRxiv) up to October 25, 2025. Of 18 eligible studies, 10 contributed complete data for meta-analysis. Statistical analyses were performed using the DerSimonian and Laird random-effects model in R (version 4.3.1). Pooled sensitivity, specificity, AUC, diagnostic odds ratio (DOR), and likelihood ratios (LR+ and LR-) were calculated. Subgroup analyses were conducted by biomarker type, platform, sample type, and disease stage. Study quality and risk of bias were assessed using QUADAS-2, the recommended tool for diagnostic accuracy studies. Results: A total of 18 studies met inclusion criteria, of which 10 contributed complete data for meta-analysis. The pooled sensitivity was 0.86 (95% CI: 0.82 - 0.89; n = 10 studies, 9,840 participants), specificity was 0.88 (95% CI: 0.84 - 0.91; n = 10 studies, 9,840 participants), and AUC was 0.90 (95% CI: 0.87 - 0.93; n = 9 studies, 8,950 participants). DOR and likelihood ratios confirmed strong diagnostic performance. Subgroup analyses showed that miRNA biomarkers outperformed lncRNA and circRNA, while electrochemical platforms demonstrated higher accuracy compared to optical and nanotechnology-based systems. Serum samples and early-stage screening yielded higher diagnostic validity. Moderate heterogeneity was observed (I² = 47 - 59%). Publication bias was detected for specificity but had limited impact after adjustment. Conclusions: Emerging screening technologies — particularly RNA biomarkers and artificial intelligence algorithms — demonstrate high diagnostic accuracy for chronic diseases in high-risk populations. These findings support the integration of advanced screening tools into health programs, resource allocation, and evidence-based policymaking.
- 26 April 2026
- Published by Brieflands in Jundishapur Journal of Chronic Disease Care
- Vol. 15 (2) , e167826
Open AccessScreening and Management Strategies for Chronic Diseases in High-Risk Populations: A Systematic Review
Context: Chronic diseases such as diabetes, cardiovascular conditions, cancers, and respiratory illnesses remain leading causes of global mortality, especially among high-risk groups including the elderly, patients with underlying conditions, and socially disadvantaged populations. Early screening and tailored management strategies are essential to reduce disease burden and improve outcomes. Methods: This systematic review and meta-analysis was conducted in line with PRISMA 2020 guidelines and registered in PROSPERO (CRD42025234789). Comprehensive searches were performed across seven databases (PubMed, Scopus, Web of Science, Embase, Cochrane Library, Google Scholar, and medRxiv) up to October 25, 2025. Of 18 eligible studies, 10 contributed complete data for meta-analysis. Statistical analyses were performed using the DerSimonian and Laird random-effects model in R (version 4.3.1). Pooled sensitivity, specificity, AUC, diagnostic odds ratio (DOR), and likelihood ratios (LR+ and LR-) were calculated. Subgroup analyses were conducted by biomarker type, platform, sample type, and disease stage. Study quality and risk of bias were assessed using QUADAS-2, the recommended tool for diagnostic accuracy studies. Results: A total of 18 studies met inclusion criteria, of which 10 contributed complete data for meta-analysis. The pooled sensitivity was 0.86 (95% CI: 0.82 - 0.89; n = 10 studies, 9,840 participants), specificity was 0.88 (95% CI: 0.84 - 0.91; n = 10 studies, 9,840 participants), and AUC was 0.90 (95% CI: 0.87 - 0.93; n = 9 studies, 8,950 participants). DOR and likelihood ratios confirmed strong diagnostic performance. Subgroup analyses showed that miRNA biomarkers outperformed lncRNA and circRNA, while electrochemical platforms demonstrated higher accuracy compared to optical and nanotechnology-based systems. Serum samples and early-stage screening yielded higher diagnostic validity. Moderate heterogeneity was observed (I² = 47 - 59%). Publication bias was detected for specificity but had limited impact after adjustment. Conclusions: Emerging screening technologies — particularly RNA biomarkers and artificial intelligence algorithms — demonstrate high diagnostic accuracy for chronic diseases in high-risk populations. These findings support the integration of advanced screening tools into health programs, resource allocation, and evidence-based policymaking.
- Open Access
- 28 February 2026
- Published by Brieflands in Jundishapur Journal of Natural Pharmaceutical Products
- Vol. 21 (1) , e169205
Pharmacological and Nutraceutical Interventions for Managing Complications in Chronic Hemodialysis Patients: A Scoping Review
Context: Patients receiving chronic hemodialysis experience a wide spectrum of complications driven by persistent oxidative stress, inflammation, metabolic abnormalities, and neurological disturbances. As interest in pharmacological and nutraceutical interventions increases, a comprehensive mapping of the existing evidence is needed to clarify therapeutic potential and guide future research. Evidence Acquisition: This scoping review followed the Arksey and O'Malley framework and the Joanna Briggs Institute methodology. A comprehensive search of PubMed, Scopus, Web of Science, Embase, Cochrane Library, Google Scholar, and medRxiv was conducted to identify studies published between January 1, 2000, and December 31, 2025. Eligible studies included clinical trials and observational studies evaluating pharmacological or nutraceutical interventions in adult hemodialysis patients. Two reviewers independently performed study selection and data extraction using predefined PCC-based eligibility criteria. Extracted data included study characteristics, intervention details, targeted complications, and outcomes. An optional quality appraisal was conducted using the Mixed Methods Appraisal Tool. Owing to heterogeneity across studies, findings were synthesized narratively. Results: A total of 18 studies met the inclusion criteria and were included in the final analysis. Interventions such as omega-3 fatty acids and gabapentin were associated with improvements in uremic pruritus, whereas melatonin was associated with improved sleep quality and regulation of circadian rhythms. Antioxidant therapies, including N-acetylcysteine, vitamin C, coenzyme Q10, alpha-lipoic acid, and green tea extract, were reported to reduce oxidative stress markers; however, effect sizes varied by dosage, duration, and study design. Evidence for cardiovascular and metabolic outcomes remained limited, and several clinically important complications, including arrhythmias, were inadequately studied. Substantial heterogeneity in outcome measures limited cross-study comparisons. Conclusions: Pharmacological and nutraceutical interventions show potential for managing several hemodialysis-related complications, particularly pruritus, sleep disturbances, and oxidative stress. However, the evidence base is limited by small sample sizes, methodological heterogeneity, and inconsistent reporting. Future research should prioritize large, rigorously designed randomized trials, standardized outcome frameworks, and broader geographic representation to improve the generalizability of the findings and support more effective patient-centered care.
- 28 February 2026
- Published by Brieflands in Jundishapur Journal of Natural Pharmaceutical Products
- Vol. 21 (1) , e169205
Open AccessPharmacological and Nutraceutical Interventions for Managing Complications in Chronic Hemodialysis Patients: A Scoping Review
Context: Patients receiving chronic hemodialysis experience a wide spectrum of complications driven by persistent oxidative stress, inflammation, metabolic abnormalities, and neurological disturbances. As interest in pharmacological and nutraceutical interventions increases, a comprehensive mapping of the existing evidence is needed to clarify therapeutic potential and guide future research. Evidence Acquisition: This scoping review followed the Arksey and O'Malley framework and the Joanna Briggs Institute methodology. A comprehensive search of PubMed, Scopus, Web of Science, Embase, Cochrane Library, Google Scholar, and medRxiv was conducted to identify studies published between January 1, 2000, and December 31, 2025. Eligible studies included clinical trials and observational studies evaluating pharmacological or nutraceutical interventions in adult hemodialysis patients. Two reviewers independently performed study selection and data extraction using predefined PCC-based eligibility criteria. Extracted data included study characteristics, intervention details, targeted complications, and outcomes. An optional quality appraisal was conducted using the Mixed Methods Appraisal Tool. Owing to heterogeneity across studies, findings were synthesized narratively. Results: A total of 18 studies met the inclusion criteria and were included in the final analysis. Interventions such as omega-3 fatty acids and gabapentin were associated with improvements in uremic pruritus, whereas melatonin was associated with improved sleep quality and regulation of circadian rhythms. Antioxidant therapies, including N-acetylcysteine, vitamin C, coenzyme Q10, alpha-lipoic acid, and green tea extract, were reported to reduce oxidative stress markers; however, effect sizes varied by dosage, duration, and study design. Evidence for cardiovascular and metabolic outcomes remained limited, and several clinically important complications, including arrhythmias, were inadequately studied. Substantial heterogeneity in outcome measures limited cross-study comparisons. Conclusions: Pharmacological and nutraceutical interventions show potential for managing several hemodialysis-related complications, particularly pruritus, sleep disturbances, and oxidative stress. However, the evidence base is limited by small sample sizes, methodological heterogeneity, and inconsistent reporting. Future research should prioritize large, rigorously designed randomized trials, standardized outcome frameworks, and broader geographic representation to improve the generalizability of the findings and support more effective patient-centered care.
- Open Access
- 31 October 2025
- Published by Brieflands in Comprehensive Health and Biomedical Studies
- Vol. 4 (2) , e169669
Integrated Management of Targeted Therapies and Metabolic Interventions to Improve Treatment Outcomes and Quality of Life in Ovarian Cancer: A Scoping Review
Context: Ovarian cancer remains one of the most lethal gynecologic malignancies, and remission outcomes are shaped by a complex interplay of clinical, genetic, therapeutic, metabolic, and psychosocial factors. Despite advances in targeted therapies and molecular diagnostics, variability in patient responses underscores the need for a comprehensive synthesis of determinants that influence remission. Evidence Acquisition: A scoping review was conducted in accordance with PRISMA guidelines. Comprehensive searches of PubMed, Scopus, Web of Science, Embase, and the Cochrane Library identified 1,450 records published between 2000 and 2024. After duplicate removal and title and abstract screening, 150 full-text articles were assessed for eligibility. Ultimately, 18 studies met the inclusion criteria and were synthesized. Data extraction focused on five domains: clinical predictors, genetic and molecular determinants, therapeutic strategies, metabolic indicators, and psychosocial influences. Tables and figures were developed to summarize the evidence, and the findings were organized into structured subsections to enhance clarity and reproducibility. Results: Clinical factors, including age, performance status, comorbidities, and biomarkers such as CA-125 kinetics, the Prognostic Nutritional Index, and systemic inflammation scores, were consistently associated with remission outcomes. Genetic and molecular analyses showed that BRCA1/2 mutations and homologous recombination defects significantly increased sensitivity to platinum-based chemotherapy and poly(ADP-ribose) polymerase inhibitors, whereas Cancer Genome Atlas profiling highlighted distinct molecular subtypes with variable remission trajectories. Therapeutic advances, including bevacizumab, dose-dense chemotherapy, and hyperthermic intraperitoneal chemotherapy, improved remission rates, particularly in high-risk and resistant disease settings. Metabolic determinants, such as malnutrition and systemic inflammation, reduced treatment tolerance, whereas psychosocial support and resilience improved adherence, immune function, and quality of life. Conclusions: Remission in ovarian cancer is influenced by multidimensional factors that extend beyond therapeutic interventions. Personalized strategies integrating molecular diagnostics, targeted therapies, nutritional optimization, and psychosocial support are essential for maximizing remission and survival outcomes. Future research should focus on refining predictive models that combine these domains, thereby advancing precision medicine and comprehensive patient care.
- 31 October 2025
- Published by Brieflands in Comprehensive Health and Biomedical Studies
- Vol. 4 (2) , e169669
Open AccessIntegrated Management of Targeted Therapies and Metabolic Interventions to Improve Treatment Outcomes and Quality of Life in Ovarian Cancer: A Scoping Review
Context: Ovarian cancer remains one of the most lethal gynecologic malignancies, and remission outcomes are shaped by a complex interplay of clinical, genetic, therapeutic, metabolic, and psychosocial factors. Despite advances in targeted therapies and molecular diagnostics, variability in patient responses underscores the need for a comprehensive synthesis of determinants that influence remission. Evidence Acquisition: A scoping review was conducted in accordance with PRISMA guidelines. Comprehensive searches of PubMed, Scopus, Web of Science, Embase, and the Cochrane Library identified 1,450 records published between 2000 and 2024. After duplicate removal and title and abstract screening, 150 full-text articles were assessed for eligibility. Ultimately, 18 studies met the inclusion criteria and were synthesized. Data extraction focused on five domains: clinical predictors, genetic and molecular determinants, therapeutic strategies, metabolic indicators, and psychosocial influences. Tables and figures were developed to summarize the evidence, and the findings were organized into structured subsections to enhance clarity and reproducibility. Results: Clinical factors, including age, performance status, comorbidities, and biomarkers such as CA-125 kinetics, the Prognostic Nutritional Index, and systemic inflammation scores, were consistently associated with remission outcomes. Genetic and molecular analyses showed that BRCA1/2 mutations and homologous recombination defects significantly increased sensitivity to platinum-based chemotherapy and poly(ADP-ribose) polymerase inhibitors, whereas Cancer Genome Atlas profiling highlighted distinct molecular subtypes with variable remission trajectories. Therapeutic advances, including bevacizumab, dose-dense chemotherapy, and hyperthermic intraperitoneal chemotherapy, improved remission rates, particularly in high-risk and resistant disease settings. Metabolic determinants, such as malnutrition and systemic inflammation, reduced treatment tolerance, whereas psychosocial support and resilience improved adherence, immune function, and quality of life. Conclusions: Remission in ovarian cancer is influenced by multidimensional factors that extend beyond therapeutic interventions. Personalized strategies integrating molecular diagnostics, targeted therapies, nutritional optimization, and psychosocial support are essential for maximizing remission and survival outcomes. Future research should focus on refining predictive models that combine these domains, thereby advancing precision medicine and comprehensive patient care.
- Open Access
- 10 December 2024
- Published by Brieflands in Comprehensive Health and Biomedical Studies
- Vol. 2 (3)
Outsourcing of Pharmacies of the Program "Family Doctor and Rural Insurance" of Comprehensive Health Service Centers of Iran
Background: This study aimed to explore the advantages, disadvantages, and outsourcing solutions for pharmacies within Iran's "Family Doctor and Rural Insurance" program at comprehensive health service centers. Methods: This qualitative research utilized the snowball method and maximum diversity sampling to conduct interviews. The criteria for participant selection included a minimum of three years of experience in the Family Doctor and Rural Insurance program and sufficient knowledge of its processes. After categorizing the data, logical connections were established using MAXQDA version 2022 software. Results: A total of 40 individuals were interviewed. The most significant benefits of outsourcing identified by respondents included improvements in quality, the use of software systems, and better management of financial resources. Key operational solutions for enhancing outsourced pharmacy services included identifying high-performing contractors, signing contracts with these contractors, and implementing a qualification test approved by the pharmaceutical affairs department under the university's vice-chancellor of health. Conclusions: To improve the delivery of services by outsourced pharmacies, it is recommended to incorporate expert opinions (particularly from pharmacists) when setting up and finalizing contracts. Additionally, a wide-scale announcement should be made to encourage greater participation from private sector pharmacies.
- 10 December 2024
- Published by Brieflands in Comprehensive Health and Biomedical Studies
- Vol. 2 (3)
Open AccessOutsourcing of Pharmacies of the Program "Family Doctor and Rural Insurance" of Comprehensive Health Service Centers of Iran
Background: This study aimed to explore the advantages, disadvantages, and outsourcing solutions for pharmacies within Iran's "Family Doctor and Rural Insurance" program at comprehensive health service centers. Methods: This qualitative research utilized the snowball method and maximum diversity sampling to conduct interviews. The criteria for participant selection included a minimum of three years of experience in the Family Doctor and Rural Insurance program and sufficient knowledge of its processes. After categorizing the data, logical connections were established using MAXQDA version 2022 software. Results: A total of 40 individuals were interviewed. The most significant benefits of outsourcing identified by respondents included improvements in quality, the use of software systems, and better management of financial resources. Key operational solutions for enhancing outsourced pharmacy services included identifying high-performing contractors, signing contracts with these contractors, and implementing a qualification test approved by the pharmaceutical affairs department under the university's vice-chancellor of health. Conclusions: To improve the delivery of services by outsourced pharmacies, it is recommended to incorporate expert opinions (particularly from pharmacists) when setting up and finalizing contracts. Additionally, a wide-scale announcement should be made to encourage greater participation from private sector pharmacies.
- Open Access
- 31 January 2024
- Published by Brieflands in Comprehensive Health and Biomedical Studies
- Vol. 2 (4)
The Relationship Between the Prevalence of Depression Caused by Antiphospholipid Syndrome Abortion and Related Factors in Pregnant Women
Background: Psychological pathologies diagnosed during pregnancy are among the risk factors affecting adverse pregnancy outcomes. Objectives: This study aimed to determine the relationship between the prevalence of depression caused by antiphospholipid syndrome (APS) abortion and related factors in pregnant women. Methods: This research is a descriptive-analytical epidemiological study. Its target population includes all patients with abortions due to APS who referred to medical centers in Ahvaz city during the academic year from October 2022 to February 2023. Forty women with a history of at least two successful births and no history of fetal death or recurrent miscarriage, similar to the studied samples, were analyzed as a control group. Two demographic questionnaires—Midwifery and Beck's Depression—were used, and the data were analyzed using SPSS24 software. Results: The linear regression test showed a significant relationship between increasing maternal age, pregnancy rate, gestational age, history of depression, and increased depression caused by abortion (P < 0.05). There was a significant relationship between higher maternal education, higher husband's education, wife's occupation, mother's employment, number of living children, history of abortions, increased family well-being, and decreased depression caused by abortion (P < 0.05). Conclusions: It is recommended to implement a new consultation-based midwifery care method in maternity centers. Additionally, by enhancing follow-up and referral systems, individuals suspected of having mood disorders after abortion can be identified and referred to specialized centers.
- 31 January 2024
- Published by Brieflands in Comprehensive Health and Biomedical Studies
- Vol. 2 (4)
Open AccessThe Relationship Between the Prevalence of Depression Caused by Antiphospholipid Syndrome Abortion and Related Factors in Pregnant Women
Background: Psychological pathologies diagnosed during pregnancy are among the risk factors affecting adverse pregnancy outcomes. Objectives: This study aimed to determine the relationship between the prevalence of depression caused by antiphospholipid syndrome (APS) abortion and related factors in pregnant women. Methods: This research is a descriptive-analytical epidemiological study. Its target population includes all patients with abortions due to APS who referred to medical centers in Ahvaz city during the academic year from October 2022 to February 2023. Forty women with a history of at least two successful births and no history of fetal death or recurrent miscarriage, similar to the studied samples, were analyzed as a control group. Two demographic questionnaires—Midwifery and Beck's Depression—were used, and the data were analyzed using SPSS24 software. Results: The linear regression test showed a significant relationship between increasing maternal age, pregnancy rate, gestational age, history of depression, and increased depression caused by abortion (P < 0.05). There was a significant relationship between higher maternal education, higher husband's education, wife's occupation, mother's employment, number of living children, history of abortions, increased family well-being, and decreased depression caused by abortion (P < 0.05). Conclusions: It is recommended to implement a new consultation-based midwifery care method in maternity centers. Additionally, by enhancing follow-up and referral systems, individuals suspected of having mood disorders after abortion can be identified and referred to specialized centers.
- Open Access
- 1 January 2024
- Published by Wiley in Journal of Immunology Research
- Vol. 2024 (1) , 4246781
Seroprevalence and Potential Risk Factors of Toxocariasis among General Population in Southwest Iran: Implications on the One Health Approach
Toxocariasis is one of the most common zoonotic diseases distributed worldwide. This study aimed to estimate the seroprevalence of anti‐Toxocara immunoglobulin G (IgG) antibodies and the associated risk factors among general populations living in urban and rural areas of Abadan and Khorramshahr cities in Khuzestan Province, Southwest Iran. This cross‐sectional study was conducted between March and September 2022. There were 363 participants (190 females and 173 males) aged from Toxocara IgG antibodies in serum samples were measured using a commercially available enzyme‐linked immunosorbent assay (ELISA). A structured questionnaire was employed to collect information regarding sociodemographic status and probable risk factors associated with toxocariasis. It was found that the seroprevalence rate in males (15.0%, 95% CI = 10.47–21.11) was higher than in females (10.5%, 95% CI = 6.92–15.70). Moreover, we observed that the seroprevalence was higher in participants at younger ages compared to other age ranges (COR = 2.55, 95% CI = 0.92–7.12, p = 0.073). The findings of the univariate analysis revealed that residency in rural areas (p < 0.001), using unpurified water (p < 0.001), contact with dog (p = 0.002), contact with soil (p < 0.001), consumption of improperly washed vegetables (p < 0.001), and history of drinking untreated water (p < 0.001) were risk factors associated with toxocariasis. Further comprehensive studies with a focus on humans and animals should be designed in different areas of the Province. The data represented by the current study are useful to health policymakers to consider precise surveillance and effective prevention measures to control this zoonotic infection among general populations.
- 1 January 2024
- Published by Wiley in Journal of Immunology Research
- Vol. 2024 (1) , 4246781
Open AccessSeroprevalence and Potential Risk Factors of Toxocariasis among General Population in Southwest Iran: Implications on the One Health Approach
Toxocariasis is one of the most common zoonotic diseases distributed worldwide. This study aimed to estimate the seroprevalence of anti‐Toxocara immunoglobulin G (IgG) antibodies and the associated risk factors among general populations living in urban and rural areas of Abadan and Khorramshahr cities in Khuzestan Province, Southwest Iran. This cross‐sectional study was conducted between March and September 2022. There were 363 participants (190 females and 173 males) aged from Toxocara IgG antibodies in serum samples were measured using a commercially available enzyme‐linked immunosorbent assay (ELISA). A structured questionnaire was employed to collect information regarding sociodemographic status and probable risk factors associated with toxocariasis. It was found that the seroprevalence rate in males (15.0%, 95% CI = 10.47–21.11) was higher than in females (10.5%, 95% CI = 6.92–15.70). Moreover, we observed that the seroprevalence was higher in participants at younger ages compared to other age ranges (COR = 2.55, 95% CI = 0.92–7.12, p = 0.073). The findings of the univariate analysis revealed that residency in rural areas (p < 0.001), using unpurified water (p < 0.001), contact with dog (p = 0.002), contact with soil (p < 0.001), consumption of improperly washed vegetables (p < 0.001), and history of drinking untreated water (p < 0.001) were risk factors associated with toxocariasis. Further comprehensive studies with a focus on humans and animals should be designed in different areas of the Province. The data represented by the current study are useful to health policymakers to consider precise surveillance and effective prevention measures to control this zoonotic infection among general populations.
- Open Access
- 3 July 2022
- Published by Universidad Tecnica de Manabi in International journal of health sciences
- p. 382-392
Comparison of obsessive beliefs, depression and anxiety in patients with suspected COVID-19 and healthy patients in Razi Hospital, Ahvaz
Introduction: The prevalence of psychological disorders has a major impact not only on mental and physical health but also on the process of treatment, recovery and duration of hospitalization and referrals. The aim of this study was to compare obsessive beliefs, depression and anxiety in patients with suspected Covid-19 and healthy individuals in Ahvaz. Methods: This descriptive-analytical study was conducted using purposive sampling method, 150 patients with Covid-19, 150 suspects and 150 healthy patients referred to Razi Hospital. Information using questionnaires Obsessive beliefs, depression and anxiety were collected and data were analyzed using multivariate analysis of variance. Results: The results showed that there were significant differences between patients with Covid-19, suspected patients and healthy individuals in terms of obsessive beliefs, depression and anxiety (p <0.001). Mean obsessive beliefs (132.35±17. 17.64) and depression (11.01±4. 4.17) were higher in patients with Covid-19 than in the other two groups (p <0.001), and anxiety (22.62 ± 5.72) was higher in patients with Covid-19 than in the other two groups. The other two groups were higher (p <0.001).
- 3 July 2022
- Published by Universidad Tecnica de Manabi in International journal of health sciences
- p. 382-392
Open AccessComparison of obsessive beliefs, depression and anxiety in patients with suspected COVID-19 and healthy patients in Razi Hospital, Ahvaz
Introduction: The prevalence of psychological disorders has a major impact not only on mental and physical health but also on the process of treatment, recovery and duration of hospitalization and referrals. The aim of this study was to compare obsessive beliefs, depression and anxiety in patients with suspected Covid-19 and healthy individuals in Ahvaz. Methods: This descriptive-analytical study was conducted using purposive sampling method, 150 patients with Covid-19, 150 suspects and 150 healthy patients referred to Razi Hospital. Information using questionnaires Obsessive beliefs, depression and anxiety were collected and data were analyzed using multivariate analysis of variance. Results: The results showed that there were significant differences between patients with Covid-19, suspected patients and healthy individuals in terms of obsessive beliefs, depression and anxiety (p <0.001). Mean obsessive beliefs (132.35±17. 17.64) and depression (11.01±4. 4.17) were higher in patients with Covid-19 than in the other two groups (p <0.001), and anxiety (22.62 ± 5.72) was higher in patients with Covid-19 than in the other two groups. The other two groups were higher (p <0.001).